An Iranian knowledge-based company succeeded in producing injection pens that are equal in quality to similar foreign ...

Possible problems: Research has found that a true growth hormone deficiency in your older years reduces strength and raises your risk of heart disease. But while growth hormone production declines ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally ...

Penumbra (PEN) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank. Research shows that stocks ...

In November, a Cabinet Minister reportedly stated at a press conference that the Reserve Bank of India (RBI) should focus on growth and not be concerned with food price inflation. Though the ...

PEN is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 34.5% year-over-year for the current fiscal year, with sales growth of 12.5%.

PEN is a #2 (Buy) on the Zacks Rank, with a VGM Score of B. Additionally, the company could be a top pick for growth investors. PEN has a Growth Style Score of A, forecasting year-over-year ...